SOURCE: BioMicro Systems, Inc.

March 06, 2007 06:00 ET

BioMicro Systems Celebrates the 350th MAUI Hybridization System Placement at the Duke Microarray Facility

SALT LAKE CITY, UT -- (MARKET WIRE) -- March 6, 2007 -- BioMicro® Systems announces the 350th MAUI® Hybridization System placement at the Duke Microarray Facility at the Center of Applied Genome Technology, Institute of Genome Institute and Policy, a key milestone for the company. Since the MAUI System launch in 2003, life sciences researchers have selected this innovative instrument to process microarray hybridizations, ensuring quality experimental results.

"Through close collaboration with the Duke Microarray Facility in placing the 350th MAUI System, BioMicro Systems is ecstatic to have such an outstanding research facility be part of this significant company milestone," said Michael Feldman, Ph.D., Chief Executive Officer of BioMicro Systems. "We strive to meet and exceed our customers' expectations in microarray hybridization data quality when utilizing the MAUI System as a key component to effectively process microarrays."

"We are very pleased with the consistent results and greatly improved analysis ratios that we have had with the MAUI Hybridization System," stated Holly Dressman, Ph.D., Director of the Duke Microarray Facility at the Center of Applied Genome Technology, Institute of Genome Institute and Policy. "Now, with three MAUI 12-Bay Systems in place, we will be more efficient and not have to worry about discrepancies in technical microarray hybridization. We are very pleased with the MAUI System and will continue with its use for many years."

BioMicro Systems key products include:

--  MAUI Hybridization System, a breakthrough microarray hybridization
    solution designed for gene expression studies
--  MAUI Mixers, a novel hybridization chamber product line enabling
    simultaneous processing of multiple microarray experiments
About BioMicro Systems, Inc.:

BioMicro Systems is a private company that serves the life sciences community by developing and marketing biological research products based on its proprietary microfluidic and microarray technologies. In 2003 BioMicro Systems launched the MAUI Hybridization System, a cutting-edge microarray hybridization instrument, designed to alleviate the processing bottleneck encountered during the microarray hybridization process and to help researchers achieve greater sensitivity and more consistent/reproducible results. BioMicro Systems strives to become the company to provide the standard for achieving superb microarray hybridization results. More company information can be found at

For MAUI System specifications, product demos, and sales information in the United States and other countries, please contact:

BioMicro Systems, Inc.
Phone: 801-303-1470
About the Duke Microarray Facility:

Under the direction of Dr. Holly Dressman, the Duke Microarray Facility provides services for the analysis of gene expression to Duke researchers and collaborators. The facility operates jointly with the Duke Comprehensive Cancer Center Shared Resource and is also supported by various NIH grants. The Microarray Facility uses two technologies, Affymetrix GeneChip arrays and custom printed oligonucleotide gene arrays, for the analysis of gene expression. More information on the Duke Microarray Facility can be found at

For additional information on services provided by the Duke Microarray Facility, please contact:

Holly K. Dressman, Ph.D.
Director, Duke Microarray Facility
Phone: 919-668-1583

Laura-Leigh Rowlette
Lab Manager, Duke Microarray Facility
Phone:  919-684-8224
©2007 BioMicro Systems, Inc. All rights reserved. BioMicro and MAUI are registered trademarks of BioMicro Systems, Inc.

Contact Information

    Katie McDaniel
    BioMicro Systems, Inc.
    Phone Number: 801-303-1470
    FAX Number: 801-303-1471
    Email Address: Email Contact
    Website Address: